Unlock Your Gleason Score: A Doctor’s Guide

By Dr. Priya Sammani ( MBBS, DFM )

I remember a patient, let’s call him John, sitting in my office, his brow furrowed as he looked at his recent biopsy report. “Doctor,” he began, his voice a little shaky, “this Gleason score… what on earth does it mean for me?” It’s a question I hear often, and honestly, it’s a really important one. If you or a loved one has been diagnosed with prostate cancer, understanding your Gleason score is a key part of understanding what’s next.

So, let’s talk about it.

What Exactly is a Gleason Score?

Simply put, a Gleason score is a grading system we use for prostate cancer. When a biopsy is done – that’s when a tiny piece of prostate tissue is taken for examination – it goes to a pathologist. These are specialist doctors who are experts at looking at cells under a microscope. They’re looking to see how much the cancer cells look like, or differ from, normal healthy prostate cells.

This score is one of the main tools we use to figure out how aggressive the cancer might be and to help us plan the best course of action. It also gives us an idea about the prognosis, which is just medical-speak for the likely outlook or course of the disease and treatment.

How Do We Get to That Number? The Calculation Explained

It’s not as complicated as it might sound. The pathologist carefully examines the prostate tissue samples.

Cancer cells, as they develop, start to change, or mutate, looking less and less like the healthy cells they once were.

The pathologist assigns a grade from 1 to 5 to the patterns of cancer cells they see:

  • Grade 1: The cancer cells look very much like normal prostate cells. They’re quite well-behaved, if you will.
  • Grades 2-4: These cells are in a sort of middle-ground. They’re clearly abnormal but haven’t gone completely rogue.
  • Grade 5: These cancer cells look very abnormal, quite different from healthy cells.

Now, here’s the key part: prostate cancer often has areas with different grades. So, the pathologist identifies the two most common patterns of cancer cells in the sample. The grade of the most common pattern is the first number, and the grade of the second most common pattern is the second number. These two numbers are then added together to get the final Gleason score.

For instance, if the largest area of cancer is graded a 3, and the next largest area is graded a 4, your Gleason score would be 7 (3+4=7). Generally, a combined score of 6 or higher is considered cancerous.

Understanding Your Gleason Score: What the Numbers Mean

You might be wondering if there’s a “normal” or “good” Gleason score. It’s a bit different from, say, a blood pressure reading where we have clear target ranges. Instead, we categorize Gleason scores to understand the cancer’s characteristics:

  • Gleason 6: Cancers with this score are usually made up of cells that still look quite a bit like normal prostate cells. We call this well-differentiated. These cancers tend to grow more slowly.
  • Gleason 7: This is a bit of a middle category. The cells are moderately-differentiated, meaning they look somewhat like healthy cells but have more noticeable abnormalities. A Gleason 7 can be either 3+4 or 4+3. A 4+3 (where the more aggressive pattern is dominant) might be slightly more concerning than a 3+4, but both fall into this intermediate group.
  • Gleason 8, 9, or 10: Cells in these cancers look very different from healthy cells. They are poorly-differentiated or even undifferentiated. These scores suggest a higher-grade cancer that might grow more quickly and could be more likely to metastasize (that’s the term for spreading to other parts of the body).

So, is a lower score “good”? Well, a lower Gleason score (like a 6) often means the cancer is less aggressive and may grow slowly. This can sometimes influence treatment decisions, perhaps allowing for options like active surveillance. But it’s not just about this one number.

The Gleason Score: Just One Piece of the Prostate Cancer Puzzle

It’s so important to remember this: your Gleason score is a crucial piece of information, but it’s not the only thing we look at. When we’re figuring out the best path forward, we consider a whole range of factors. Think of it like building a complete picture.

Other things we’ll discuss include:

  • Your PSA (prostate-specific antigen) level from your blood test.
  • What we found during a digital rectal exam (DRE).
  • Results from imaging tests, which might include an ultrasound, MRI (magnetic resonance imaging), or sometimes a PET (positron emission tomography) scan.
  • How many of the biopsy samples (we call these cores) contained cancer cells.
  • Whether cancer cells were found in most of the tissue within those cores.
  • If the cancer is present on one or both sides of your prostate.
  • And, crucially, whether there’s any evidence the cancer has spread beyond the prostate.

We put all these pieces together to understand your specific situation.

Take-Home Message: Understanding Your Gleason Score

Facing a prostate cancer diagnosis can be overwhelming, I know. But understanding terms like the Gleason score can empower you. Here’s what to keep in mind:

  • The Gleason score grades prostate cancer based on how abnormal cells look under a microscope.
  • It’s calculated by adding the grades (1-5) of the two most common cancer patterns found in your biopsy.
  • Scores range from 6 (lower-grade, often slower-growing) to 10 (higher-grade, potentially more aggressive).
  • A Gleason score of 6 is considered well-differentiated.
  • A score of 7 is moderately-differentiated.
  • Scores of 8, 9, or 10 are poorly-differentiated or undifferentiated.
  • Crucially, your Gleason score is just one factor among many that helps us determine the best treatment plan and outlook.

We’ll discuss all these details and what they mean for you, specifically. We’ll go over all the options and make decisions together.

You’re not alone in this. We’re here to walk through it with you, every step of the way.

Dr. Priya Sammani
Medically Reviewed by
MBBS, Postgraduate Diploma in Family Medicine
Dr. Priya Sammani is the founder of Priya.Health and Nirogi Lanka. She is dedicated to preventive medicine, chronic disease management, and making reliable health information accessible for everyone.
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments